vs

Side-by-side financial comparison of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($221.4M vs $213.6M, roughly 1.0× Vital Farms, Inc.). Vital Farms, Inc. runs the higher net margin — 7.6% vs 0.2%, a 7.4% gap on every dollar of revenue. On growth, Vital Farms, Inc. posted the faster year-over-year revenue change (28.7% vs 6.7%). Over the past eight quarters, Vital Farms, Inc.'s revenue compounded faster (20.2% CAGR vs 11.7%).

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".

UTI vs VITL — Head-to-Head

Bigger by revenue
UTI
UTI
1.0× larger
UTI
$221.4M
$213.6M
VITL
Growing faster (revenue YoY)
VITL
VITL
+21.9% gap
VITL
28.7%
6.7%
UTI
Higher net margin
VITL
VITL
7.4% more per $
VITL
7.6%
0.2%
UTI
Faster 2-yr revenue CAGR
VITL
VITL
Annualised
VITL
20.2%
11.7%
UTI

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
UTI
UTI
VITL
VITL
Revenue
$221.4M
$213.6M
Net Profit
$433.0K
$16.3M
Gross Margin
35.8%
Operating Margin
0.2%
10.0%
Net Margin
0.2%
7.6%
Revenue YoY
6.7%
28.7%
Net Profit YoY
-60.5%
54.3%
EPS (diluted)
$0.01
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UTI
UTI
VITL
VITL
Q1 26
$221.4M
Q4 25
$220.8M
$213.6M
Q3 25
$222.4M
$198.9M
Q2 25
$204.3M
$184.8M
Q1 25
$207.4M
$162.2M
Q4 24
$201.4M
$166.0M
Q3 24
$196.4M
$145.0M
Q2 24
$177.5M
$147.4M
Net Profit
UTI
UTI
VITL
VITL
Q1 26
$433.0K
Q4 25
$12.8M
$16.3M
Q3 25
$18.8M
$16.4M
Q2 25
$10.7M
$16.6M
Q1 25
$11.4M
$16.9M
Q4 24
$22.2M
$10.6M
Q3 24
$18.8M
$7.4M
Q2 24
$5.0M
$16.3M
Gross Margin
UTI
UTI
VITL
VITL
Q1 26
Q4 25
35.8%
Q3 25
37.7%
Q2 25
38.9%
Q1 25
38.5%
Q4 24
36.1%
Q3 24
36.9%
Q2 24
39.1%
Operating Margin
UTI
UTI
VITL
VITL
Q1 26
0.2%
Q4 25
7.1%
10.0%
Q3 25
11.2%
10.8%
Q2 25
6.9%
12.9%
Q1 25
8.1%
13.4%
Q4 24
13.6%
7.8%
Q3 24
13.3%
6.4%
Q2 24
4.2%
11.6%
Net Margin
UTI
UTI
VITL
VITL
Q1 26
0.2%
Q4 25
5.8%
7.6%
Q3 25
8.4%
8.3%
Q2 25
5.2%
9.0%
Q1 25
5.5%
10.4%
Q4 24
11.0%
6.4%
Q3 24
9.6%
5.1%
Q2 24
2.8%
11.1%
EPS (diluted)
UTI
UTI
VITL
VITL
Q1 26
$0.01
Q4 25
$0.23
$0.35
Q3 25
$0.33
$0.36
Q2 25
$0.19
$0.36
Q1 25
$0.21
$0.37
Q4 24
$0.40
$0.23
Q3 24
$0.35
$0.16
Q2 24
$0.09
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UTI
UTI
VITL
VITL
Cash + ST InvestmentsLiquidity on hand
$162.0M
$48.8M
Total DebtLower is stronger
$127.8M
Stockholders' EquityBook value
$339.9M
$351.3M
Total Assets
$852.2M
$518.7M
Debt / EquityLower = less leverage
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UTI
UTI
VITL
VITL
Q1 26
$162.0M
Q4 25
$162.8M
$48.8M
Q3 25
$169.1M
$93.8M
Q2 25
$70.7M
$108.2M
Q1 25
$96.0M
$156.3M
Q4 24
$172.0M
$150.6M
Q3 24
$161.9M
$149.5M
Q2 24
$115.5M
$133.2M
Total Debt
UTI
UTI
VITL
VITL
Q1 26
$127.8M
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
UTI
UTI
VITL
VITL
Q1 26
$339.9M
Q4 25
$335.9M
$351.3M
Q3 25
$328.1M
$331.2M
Q2 25
$306.8M
$309.8M
Q1 25
$293.9M
$288.9M
Q4 24
$280.0M
$269.3M
Q3 24
$260.2M
$253.4M
Q2 24
$239.4M
$238.4M
Total Assets
UTI
UTI
VITL
VITL
Q1 26
$852.2M
Q4 25
$834.0M
$518.7M
Q3 25
$826.1M
$481.5M
Q2 25
$740.8M
$430.8M
Q1 25
$720.4M
$376.9M
Q4 24
$753.8M
$359.3M
Q3 24
$744.6M
$344.7M
Q2 24
$706.0M
$320.5M
Debt / Equity
UTI
UTI
VITL
VITL
Q1 26
0.38×
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UTI
UTI
VITL
VITL
Operating Cash FlowLast quarter
$7.1M
$5.8M
Free Cash FlowOCF − Capex
$-32.1M
FCF MarginFCF / Revenue
-15.1%
Capex IntensityCapex / Revenue
17.8%
Cash ConversionOCF / Net Profit
16.33×
0.35×
TTM Free Cash FlowTrailing 4 quarters
$-48.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UTI
UTI
VITL
VITL
Q1 26
$7.1M
Q4 25
$3.1M
$5.8M
Q3 25
$57.1M
$23.4M
Q2 25
$18.1M
$-761.0K
Q1 25
$-789.0K
$5.3M
Q4 24
$23.0M
$14.8M
Q3 24
$67.5M
$10.0M
Q2 24
$10.0M
$16.1M
Free Cash Flow
UTI
UTI
VITL
VITL
Q1 26
Q4 25
$-19.2M
$-32.1M
Q3 25
$40.6M
$-10.6M
Q2 25
$6.8M
$-7.6M
Q1 25
$-11.7M
$2.1M
Q4 24
$19.6M
$-3.4M
Q3 24
$60.0M
$6.4M
Q2 24
$3.0M
$10.5M
FCF Margin
UTI
UTI
VITL
VITL
Q1 26
Q4 25
-8.7%
-15.1%
Q3 25
18.3%
-5.3%
Q2 25
3.4%
-4.1%
Q1 25
-5.7%
1.3%
Q4 24
9.7%
-2.0%
Q3 24
30.6%
4.4%
Q2 24
1.7%
7.2%
Capex Intensity
UTI
UTI
VITL
VITL
Q1 26
Q4 25
10.1%
17.8%
Q3 25
7.4%
17.1%
Q2 25
5.5%
3.7%
Q1 25
5.3%
1.9%
Q4 24
1.7%
10.9%
Q3 24
3.8%
2.5%
Q2 24
4.0%
3.8%
Cash Conversion
UTI
UTI
VITL
VITL
Q1 26
16.33×
Q4 25
0.24×
0.35×
Q3 25
3.04×
1.43×
Q2 25
1.69×
-0.05×
Q1 25
-0.07×
0.31×
Q4 24
1.04×
1.40×
Q3 24
3.58×
1.34×
Q2 24
2.01×
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UTI
UTI

Segment breakdown not available.

VITL
VITL

Eggs And Egg Related Products$205.8M96%
Butter And Butter Related Products$7.7M4%

Related Comparisons